The global allergy diagnostics market size was valued at USD 7.09 billion in 2025 and is projected to reach USD 16.37 billion by 2033, growing at a CAGR of 11.29% from 2026 to 2033. The growth is driven by the rising incidence of conditions such as allergic rhinitis, asthma, atopic dermatitis, and food allergies, which are becoming more common due to environmental pollution, urbanization, and lifestyle changes. Increasing awareness regarding early allergy detection and the growing demand for accurate diagnostic solutions are also contributing significantly to market growth worldwide.

Allergy diagnostics are widely used to identify allergens responsible for triggering allergic reactions in patients. These diagnostic procedures help healthcare providers determine appropriate treatment plans and preventive measures for individuals suffering from allergies. Rising healthcare expenditure, increasing prevalence of respiratory disorders, and growing focus on personalized healthcare are supporting the expansion of the allergy diagnostics market. In addition, advancements in diagnostic technologies and increasing accessibility to allergy testing services are improving the adoption of allergy diagnostics across healthcare facilities.

Download a free sample copy of the Allergy Diagnostics market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• North America allergy diagnostics market held the largest share of 36.62% of the global market in 2025. The region’s dominance is primarily attributed to the high prevalence of allergic diseases, advanced healthcare infrastructure, strong awareness regarding allergy testing, and increasing healthcare spending. The presence of major diagnostic companies and growing adoption of technologically advanced diagnostic solutions are also supporting market growth across North America. In addition, rising environmental pollution levels and changing lifestyle patterns continue to contribute to the increasing incidence of allergies within the region.
• The allergy diagnostics industry in the U.S. is expected to grow significantly over the forecast period. The country continues to witness rising cases of asthma, food allergies, and respiratory allergic conditions among both children and adults. Increasing demand for early diagnosis and effective allergy management solutions is driving the adoption of advanced allergy testing procedures across hospitals, clinics, and diagnostic laboratories. In addition, strong healthcare infrastructure and growing awareness regarding preventive healthcare are contributing to market expansion in the U.S.
• By products and services, the consumables segment held the highest market share of 63.21% in 2025. Consumables used in allergy diagnostics include reagents, assay kits, test strips, and laboratory supplies required for conducting allergy tests. The large market share of this segment is attributed to the recurring demand for diagnostic testing materials across healthcare facilities and laboratories. Increasing testing volumes and rising adoption of in-vitro diagnostic procedures are further supporting the growth of the consumables segment.
• By allergen, the inhaled segment held the highest market share in 2025. Inhaled allergens such as pollen, dust mites, mold spores, and animal dander are among the most common triggers of allergic reactions globally. Rising air pollution levels, urbanization, and changing environmental conditions are contributing significantly to the increasing prevalence of respiratory allergies. Growing awareness regarding respiratory health and increasing demand for allergy testing are supporting the growth of the inhaled allergen segment.
• By test type, the in-vitro segment held the highest market share in 2025. In-vitro allergy testing methods are widely preferred due to their accuracy, safety, convenience, and ability to analyze multiple allergens simultaneously. These tests are commonly performed using blood samples and are increasingly adopted across hospitals, clinics, and diagnostic laboratories. Rising preference for minimally invasive diagnostic procedures and increasing advancements in laboratory technologies are contributing to the growth of the in-vitro testing segment.
• By end use, hospitals & clinics held the highest market share in 2025. Hospitals and clinics remain the primary healthcare settings for allergy diagnosis and treatment due to the availability of advanced diagnostic equipment, skilled healthcare professionals, and specialized allergy care services. Increasing patient visits related to allergic conditions and rising demand for accurate diagnostic testing are supporting segment growth. In addition, expanding healthcare infrastructure and growing focus on early disease diagnosis are contributing to the increasing adoption of allergy diagnostics across hospitals and clinics.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The allergy diagnostics market is driven by a cohort of specialized diagnostics and biotechnology companies that are advancing the field through continuous innovation, technological advancements, strategic partnerships, and portfolio expansion across in vitro and in vivo allergy testing.

These companies are at the forefront of developing advanced allergy diagnostic solutions such as immunoassays, molecular allergy diagnostics, skin prick testing devices, and point-of-care testing platforms, addressing both respiratory and food allergies. For instance, in April 2025, Beckman Coulter Life Sciences announced the launch of its next-generation Basophil Activation Test (BAT), designed to enhance food allergy research by providing a safer and more efficient alternative to traditional testing methods. Similarly, HYCOR Biomedical continues to innovate with its NOVEOS System, focusing on automation and improved sensitivity in allergy testing. These ongoing innovations, coupled with strategic collaborations and regulatory approvals, are expected to drive significant advancements in the market, enabling earlier detection, better differentiation of allergens, and improved patient outcomes.

Key Allergy Diagnostics Companies:

• Thermo Fisher Scientific, Inc.
• HYCOR Biomedical
• EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
• Omega Diagnostics Group PLC
• Lincoln Diagnostics, Inc.
• AESKU.GROUP GmbH
• Minaris Medical America, Inc.
• HOB Biotech Group Corp., Ltd.
• DASIT Group SPA
• R-Biopharm AG
• bioMérieux
• Siemens Healthcare GmbH

Explore Grand View Horizon to see global and regional level statistics related to the Allergy Diagnostics Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering